Explore Prime Medicine stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for PRME.

Shares of Prime Medicine (NASDAQ: PRME) are surging on Thursday. The gene-editing company's stock gained 10.5% as of 2 p.m.

Arguably the more significant of the two pieces of news was that partnership deal. Prime Medicine announced that it had signed a strategic research collaboration and license agreement with global ...

Shares of Prime Medicine, Inc. (NASDAQ:PRME) fell 19.2% following the company’s announcement of a strategic restructuring focused on large genetic liver diseases and cystic fibrosis, alongside ...

Prime Medicine Inc does not currently pay a dividend or dividend information is unavailable. Prime Medicine Inc last traded ex-dividend on Sep 10, 2019 and the next ex-dividend date is unknown.

Shares of Prime Medicine (NASDAQ: PRME) are surging on Thursday. The gene-editing company's stock gained 10.5% as of 2 p.m. ET and was up as much as 17% earlier in the day. The move up comes as ...

Why Prime Medicine Stock Soared Nearly 12% Higher on Monday. Eric Volkman, The Motley Fool . Mon, Sep 30, 2024, 6:08 PM 2 min read. In This Article: PRME .

Before you buy stock in Prime Medicine, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now ...

Shares of Prime Medicine (PRME 1.03%) are surging on Thursday. The gene-editing company's stock gained 10.5% as of 2 p.m. ET and was up as much as 17% earlier in the day.

Why Prime Medicine Stock Was Climbing Higher This Week. Why Prime Medicine Stock Is Soaring Today. 2 Growth Stocks That Could Make You Richer. 2 Magnificent Growth Stocks With Room to Run.